# Single Doses GSK159797 On Patient Safety And Lung Function In Patients With Mild To Moderate Asthma

> **NCT00354666** · PHASE2 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 20 (—)

## Conditions studied

- Pulmonary Disease, Chronic Obstructive

## Interventions

- **DRUG:** GSK159797

## Key facts

- **NCT ID:** NCT00354666
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-09
- **Primary completion:** —
- **Final completion:** 2004-12
- **Target enrollment:** 20 (—)
- **Last updated:** 2016-09-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00354666

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00354666, "Single Doses GSK159797 On Patient Safety And Lung Function In Patients With Mild To Moderate Asthma". Retrieved via AI Analytics 2026-08-18 from https://api.ai-analytics.org/clinical/NCT00354666. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*